CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 4 Grant or award Director acquired 34,387 shares (grant or award)
- 8-K Event Executive or director change
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award SVP, Controller & CAO acquired 16,898 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- SD Other Specialized Disclosure
- 4 Open-market sale 10% owner sold 4,550,357 shares at $17.06 ($77,606,339)
Page 18 of 121 · 2,419 filings